CNS Pharmaceuticals (CNSP) 10-K/A 2020 FY Annual report (amended)

EXHIBIT 31.2

CERTIFICATION BY OFFICER

I, Christopher Downs, certify that:

1. I have reviewed this Form 10-K/A for the year ended December 31, 2020 of CNS Pharmaceuticals, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Date: April 30, 2021	By:	/s/ Christopher Downs
		Christopher Downs
		Chief Financial Officer